Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972889 · ClinicalTrials.gov registry record · NA
Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP
A NA study of Non-Specific Chronic Lower Back Pain, sponsored by Zynex Medical.
- Completed
- Registry status
- NA
- Development phase
- 334
- Enrollment target
- 8
- Study locations
NCT05972889: Completed NA study of Non-Specific Chronic Lower Back Pain, sponsored by Zynex Medical.
NCT05972889 is a NA study of Non-Specific Chronic Lower Back Pain that has completed, run by Zynex Medical. The registered enrollment target is 334 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05972889, a NA study of Non-Specific Chronic Lower Back Pain, has completed, sponsored by Zynex Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 334 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.
Primary Outcome
VAS pain rating between baseline and four weeks for NexWave subjects as compared to sham device subjects.
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE NexWave
Study Locations (8)
Georgia
- Peachtree Orthopedics - Atlanta
- Horizon Clinical Research - Jasper
Colorado
- DBPS Research - Greenwood Village
Florida
- McGreevy NeuroHealth - Saint Augustine
Illinois
- Applied Pain Institute, LLC - Bloomington
New York
- One Oak Medical - Congers
North Carolina
- The Center for Clinical Research, LLC - Winston-Salem
Utah
- Summit Brain, Spine and Orthopedics - Lehi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2023-11-02 |
| Est. Completion | 2025-10-21 |
| Phase | NA |
What the finished NCT05972889 record still lists
NCT05972889 is an interventional study that assigns participants to a tested intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Non-Specific Chronic Lower Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT05972889 lists 8 locations in 7 states (Georgia, Colorado, Florida).
Frequently Asked Questions
What is clinical trial NCT05972889 about?
NCT05972889 is a clinical study titled "Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP". This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined stand...
What is the current status of trial NCT05972889?
This trial is currently completed. It is a NA study. The enrollment target is 334 participants. The study started on 2023-11-02. Estimated completion is 2025-10-21.
What conditions does trial NCT05972889 study?
This clinical trial studies the following conditions: Non-Specific Chronic Lower Back Pain.
What interventions are being tested in trial NCT05972889?
The interventions under investigation include: Sham (DEVICE), NexWave (DEVICE).
Who is sponsoring clinical trial NCT05972889?
This trial is sponsored by Zynex Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05972889 being conducted?
This trial has 8 study locations across Colorado, Florida, Georgia, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05972889's enrollment target sits among peer trials
334 305th of 2000 higher than 1,695 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI